Potential chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis in rats: Myrrh (Commiphora molmol) vs. turmeric (Curcuma longa)

Acta Histochemica

Volumn 114, Issue 5, 2012, Pages 421-428

  El Shahat, Mohamed ^a   El Abd, Sabah ^a   Alkafafy, Mohamed ^a   El Khatib, Gamal ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

CD10; Diethylnitrosamine; Hepatocarcinogenesis; Immunohistochemistry; Myrrh; Rats; Turmeric

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; LIVER ENZYME; MYRRH; NITRIC OXIDE; TURMERIC; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHEMOPROPHYLAXIS; COMMIPHORA; CONTROLLED STUDY; CURCUMA LONGA; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER PROTECTION; MALE; NONHUMAN; RAT; WISTAR RAT;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARCINOMA, HEPATOCELLULAR; CURCUMA; DIETARY SUPPLEMENTS; DIETHYLNITROSAMINE; LIVER NEOPLASMS; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; TERPENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

COMMIPHORA; COMMIPHORA HABESSINICA; CURCUMA LONGA; RATTUS; RATTUS NORVEGICUS;

EID: 84860361968     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2011.08.002     Document Type: Article

References (42)

1. Aggarwal B.B., Shishodia S., Takada Y., Banerjee S., Newman R.A., Bueso-Ramos C.E., et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 2005, 11:7490-7498.
2. al-Harbi M.M., Qureshi S., Ahmed M.M., Rafatulla S., Shah A.H. Effect of Commiphora molmol (oleo-gum-resin) on the cytological and biochemical changes induced by cyclophosphamide in mice. Am J Chin Med 1994, 22:77-82.
3. al-Harbi M.M., Qureshi S., Raza M., Ahmed M.M., Giangreco A.B., Shah A.H. Anticarcinogenic effect of Commiphora molmol on solid tumors induced by Ehrlich carcinoma cells in mice. Chemotherapy 1994, 40:337-347.
4. Al-Rejaie S.S., Aleisa A.M., Al-Yahya A.A., Bakheet S.A., Alsheikh A., Fatani A.G., et al. Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats. World J Gastroenterol 2009, 15:1373-1380.
5. Ammon H.P., Wahl M.A. Pharmacology of Curcuma longa. Planta Med 1991, 57:1-7.
6. Atsumi T., Murakami Y., Shibuya K., Tonosaki K., Fujisawa S. Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression, by curcumin and its analog, alpha-diisoeugenol. Anticancer Res 2005, 25:4029-4036.
7. Bancroft J.D., Stevens A., Turner D.R. Theory and Practice of Histological Techniques 1996, Churchill Livingstone, London, Toronto. 4th ed.
8. Borscheri N., Roessner A., Röcken C. Canalicular staining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas. Am J Surg Pathol 2001, 25:1297-1303.
9. Burits M., Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res 2000, 14:323-328.
10. Cao Y., Chen H., Zhou L., Chiang M.K., Anand-Apte B., Weatherbee J.A., et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem 1996, 271:3154-3162.
11. Chakraborty T., Chatterjee A., Rana A., Dhachinamoorthi D., Kumar P.A., Chatterjee M. Carcinogen-induced early molecular events and its implication in the initiation of chemical hepatocarcinogenesis in rats: chemopreventive role of vanadium on this process. Biochim Biophys Acta 2007, 1772:48-59.
12. Chu P., Arber D.A. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 2000, 113:374-382.
13. Chuang S.E., Kuo M.L., Hsu C.H., Chen C.R., Lin J.K., Lai G.M., et al. Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 2000, 21:331-335.
14. Ciemniak A.A. Comparison of N-nitrosodimethylamine contents in selected meat products. Rocz Panstw Zakl Hig 2006, 57:341-346. [abstract].
15. Dolara P., Corte B., Ghelardini C., Pugliese A.M., Cerbai E., Menichetti S., et al. Local anaesthetic, antibacterial and antifungal properties of sesquiterpenes from myrrh. Planta Med 2000, 66:356-358.
16. Goel A., Boland C.R., Chauhan D.P. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 2001, 172:111-118.
17. Harris C.C., Sun T. Multifactoral etiology of human liver cancer. Carcinogenesis 1984, 5:697-701.
18. Kind P.R., King E.J. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol 1954, 7:322-326.
19. Lampe J.W. Spicing up a vegetarian diet: chemopreventive effects of phytochemicals. Am J Clin Nutr 2003, 78(3 Suppl.):579S-583S.
20. Lee H.S., Kim W.H., Kang G.H. Hepatocyte expressions in hepatocellular carcinomas, gastrointestinal neoplasms, and non-neoplastic gastrointestinal mucosa: its role as a diagnostic marker. J Kor Med Sci 2003, 18:842-848.
21. McIntosh G.G., Lodge A.J., Watson P., Hall A.G., Wood K., Anderson J.J., et al. NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol 1999, 154:77-82.
22. Montgomery H.A.C., Dymock J.F. The determination of nitrite in water. Analyst 1961, 86:414-416.
23. Nakamura T. Changes in expression of bile canalicular CD10 and sinusoidal CD105 (endoglin) in peritumoral hepatic tissue. Tumori 2009, 95:495-500.
24. Piper J.T., Singhal S.S., Salameh M.S., Torman R.T., Awasthi Y.C., Awasthi S. Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int J Biochem Cell Biol 1998, 30:445-456.
25. Plaa G.L., Hewitt W.R. Detection and evaluation of chemically induced liver injury. Principles and Methods of Toxicology 1989, 399-428. Raven Press, New York. 2nd ed. A. Wallace Hayes (Ed.).
26. Rajeshkumar N.V., Kuttan R. Inhibition of N-nitrosodiethylamine-induced hepatocarcinogenesis by Picroliv. J Exp Clin Cancer Res 2000, 19:459-465.
27. Reitman S., Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957, 28:56-63.
28. Ritz J., Pesando J.M., Notis-McConarty J., Lazarus H., Schlossman S.F. A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature 1980, 283:583-585.
29. Sadik N.A., EL-Maraghy S.A., Ismail M.F. Diethylnitrosamine-induced hepatocarcinogenesis in rats: possible chemoprevention by blueberries. Afr J Biochem Res 2008, 2:81-87.
30. Sharma R. Recommendations on herbs and herbal formula in cancer prevention. Open Nutraceut J 2010, 3:129-140.
31. Sharma R.A., Ireson C.R., Verschoyle R.D., Hill K.A., Williams M.L., Leuratti C., et al. Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels. Clin Cancer Res 2001, 7:1452-1458.
32. Sharma R.A., McLelland H.R., Hill K.A., Ireson C.R., Euden S.A., Manson M.M., et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001, 7:1894-1900.
33. Sharma R.A., Gescher A.J., Steward W.P., Curcumin: the story so far. Eur J Cancer 2005, 41:1955-1968.
34. Shi S.R., Cote R.J., Taylor C.R. Antigen retrieval techniques: current perspectives. J Histochem Cytochem 2001, 49:931-937.
35. Srinivas L., Shalini V.K., Shylaja M. Turmerin: a water-soluble antioxidant peptide from turmeric (Curcuma longa). Arch Biochem Biophys 1992, 292:617-623.
36. Tariq M., Ageel A.M., Al-Yahya M.A., Mossa J.S., Al-Said M.S., Parmar N.S. Anti-inflammatory activity of Commiphora molmol. Agents Actions 1986, 17:381-382.
37. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160:1-40.
38. van den Bos I.C., Hussain S.M., Dwarkasing R.S., Stoop H., Zondervan P.E., Krestin G.P., et al. Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma. Br J Radiol 2007, 80:e317-e320.
39. Vareed S.K., Kakarala M., Ruffin M.T., Crowell J.A., Normolle D.P., Djuric Z., et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008, 17:1411-1417.
40. Verna L., Whysner J., Williams G.M. N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 1996, 71:57-81.
41. Ward S.C., Huang J., Tickoo S.K., Thung S.N., Ladanyi M., Klimstra D.S. Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation. Mod Pathol 2010, 23:1180-1190.
42. Xiao S.Y., Wang H.L., Hart J., Fleming D., Beard M.R. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Am J Pathol 2001, 159:1415-1421.